MedPath

Efficacy Evaluation Of Skin Fairness Creams On Healthy Human Volunteers

Phase 2
Completed
Registration Number
CTRI/2011/11/002134
Lead Sponsor
ITC Research and Development centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
320
Inclusion Criteria

Subjects willing to give a written informed consent and come for regular follow up.

Female subjects in generally good health, in the age group of 18 - 45 years.

Subjects having Chromameter L value between 40-60 on cheeks and L value at least 3 units higher than the cheeks on upper volar bicep region.

Subject, who get Sun exposure for atleast 20-40 mins per day.

At least 5 subjects under each treatment group having acne prone skin.

At least 5 subjects under each treatment group having few hyper-pigmentation spots on face like solar lentigines and /or post acne dark spots other than melasma/ nevi etc.

Subjects willing to abstain from using other cosmetic/ medicinal/ ayurvedic/ natural products on face during the study course.

Exclusion Criteria

A known history or present condition of Allergic response to any cosmetic product

Subject having skin disease (e.g. psoriasis, atopic dermatitis or other cutaneous manifestations), which would interfere with the test readings

Subjects having Melasma/ Chloasma/ Nevi/ Post inflammatory hyperpigmentation marks and other forms of severe photo damage at the site of evaluation (Except Hyper-pigmentary age spots/ small post acne marks)

Subjects on medications (e.g. steroids or antihistamines), which could compromise the study results

Pregnant/ nursing females

Subjects who are involved in physical labor work

Subjects with tattoos, dense hair, moles, warts on face and volar forearms at the site of evaluation.

Subjects with known sensitivity to sun, sunscreens/ cosmetics/ fragrances

Subjects having participated in a similar investigation in the past four

weeks

Subjects having used a similar product for the last two weeks (Washout period)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)To evaluate the efficacy of fairness cream formulations in conferring skin fairness, radiance and glow, moisturization, softness, smoothness and healthy appearance in comparison to baseline and to other investigational products.2)To evaluate the efficacy of fairness cream formulations in reducing Sun induced tanning and associated photodamage in terms of dark spots and wrinkling in comparison to baseline and to other investigational products.Timepoint: 6 Weeks
Secondary Outcome Measures
NameTimeMethod
?To evaluate the safety of fairness cream formulations on all skin types including acne prone skin. <br/ ><br> <br/ ><br>?To evaluate the efficacy of fairness cream formulations in conferring even tone, clear skin, young appearing skin in comparison to baseline, placebo and other investigational products.Timepoint: 6 Weeks
© Copyright 2025. All Rights Reserved by MedPath